Quick Hits: FDA Approves Innovative Therapy for Non-Hodgkin Lymphoma & New Biosimilar for Avastin

Quick Hits: Transvaginal Mesh Pulled, New Weight Loss Drug & More

FDA approves CAR T-cell therapy to treat adults with certain types of large B-cell lymphoma. The FDA approved a cell-based gene therapy known as Yescarta (axicabtagene ciloleucel) to treat adult patients with certain types of non-Hodgkin lymphoma. Yescarta is intended for patients who have failed at least 2 other cancer therapies. The new treatment has a boxed warning for cytokine release syndrome (CRS) — a significant inflammatory response — and for neurologic toxicities, which can be fatal or life-threatening. Yescarta was approved with a risk evaluation and mitigation strategy (REMS), which includes elements to assure safe use (ETASU). This means that centers that administer the treatment need to be trained and certified to manage the potential for CRS and neurologic toxicities. Posted October 18, 2017. Via FDA.

FDA approves first biosimilar for the treatment of cancer. The FDA approved Mvasi as a biosimilar to Avastin (bevacizumab) for the treatment of certain colorectal, lung, brain, kidney and cervical cancers. A biosimilar is a biologic medication that is considered interchangeable with a brand-name biologic and is not significantly different in terms of safety and effectiveness. They also tended to be drastically cheaper.

Some serious side effects associated with Mvasi — as well as Avastin — blood clot formation, hypertension, problems in brain function or structure, and ovarian failure. Mvasi, like Avastin, also contains a boxed warning about an increased risk of holes in the stomach and intestines, potential complications in healing from surgery and an increased risk of hemorrhaging in various parts of the body. Posted September 14, 2017. Via FDA.


Avatar

Alanna M.

Alanna M. is a graduate of Pace University.


Did you find this article helpful?


Leave a Reply

Your email address will not be published. Required fields are marked *

Latest News

Covid-19: Side Effects of Trump’s Treatments

Covid-19: Side Effects of Trump’s Treatments

President Donald Trump announced (via Twitter, of course) what some considered unthinkable, and others considered inevitable — that he had tested positive for Covid-19. Over the weekend, he received various treatments  — supplements like vitamin D, zinc and melatonin, an experimental antibody combination, an antiviral drug and a powerful anti-inflammatory…

Un-Sheltering Tips for Your Health and Immune System

Un-Sheltering Tips for Your Health and Immune System

As we all emerge from our bubbles of limited contact with others, we are walking straight into the double whammy of flu season and COVID-19 germs. Can your body fight off exposure to the flu and COVID? Your immune system feeds off the basics of life — sleep, movement, food…